PTC

Crimson Hexagon is a data analytics company based in Boston, MA. They specialize in providing social media analysis and insights to help businesses make informed decisions. Utilizing advanced technology and algorithms, Crimson Hexagon offers a platform that enables clients to monitor and analyze online conversations, trends, and consumer sentiments across various social media platforms. Generated from their business information

Donovan Hatem LLP is a multi-practice law firm based in Boston, MA, offering specialized legal counsel to architectural and engineering firms, public and private companies, nonprofit organizations, government entities, and individuals since 2001. Their team of experienced attorneys provides comprehensive advice and guidance in areas such as business litigation, corporate law, employment practices, environmental practices, government relations, insurance tort litigation, product liability, professional practices, and real estate. Known for their expertise in professional liability and risk management, Donovan Hatem LLP attorneys frequently lecture nationwide on these topics and are widely published in industry periodicals, law reviews, and regional and national publications. With a focus on minimizing risk, the firm provides strategic advice and high-level guidance to their diverse clientele when needed.Generated from the website

Alexion Pharmaceuticals is engaged in the discovery and development of therapeutic products aimed at treating patients with an array of diseases, including hematologic and cardiovascular disorders, autoimmune diseases and cancer. Alexion's two primary product candidates, pexelizumab and eculizumab, are currently undergoing evaluation in several clinical development programs with the Federal Drug Administration. Alexion is engaged in discovering and developing a pipeline of additional antibody therapeutics targeting severe unmet medical needs, through its wholly owned subsidiary, Alexion Antibody Technologies. During the fiscal year ended July 31, 2005, eculizumab was in Phase III clinical development for treatment of paroxysmal nocturnal hemoglobinuria , a chronic hematologic disease, and pexelizumab was in clinical development for two acute cardiac indications. Alexion is also pursuing additional potential indications for eculizumab and has other product candidates in earlier stages of development. Alexion Pharmaceuticals is based in Cheshire, Conn.